CRP and hepatocellular carcinoma: Third (RQ3), which biomarkers show specific malleability over the short-term, in response to the intervention? We hypothesized that participants who engaged in the intervention would show reduced CRP, EBV, and HCC, indexing a beneficial regulation of inflammatory processes, immune competence, and neuroendocrine stress.